BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 27, 2026
See today's BioWorld
Home
» Other news to note for Oct. 26, 2021
To read the full article
sign up for free
or
sign in
.
Other news to note for Oct. 26, 2021
Oct. 26, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 180 Life Sciences, Bicycle, BMS, Boehringer, Denali, Diverse, Eyegate, Ginkgo, I-Mab, Johnson & Johnson, Mabylon, Merck, Mind, Moderna, Nippon Kayaku, Novartis, Protagonist, Scineuro, Secarna, Selecta, Sinopharm, Solasia, Taysha, TCR2, Titan, Tremeau, Ubiquigent, Vyne, Xeris.
BioWorld
Briefs
Other news to note
Coronavirus